Today: 4 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Crypto ATM Scams Surge in December 2025 as Police, States and Seniors Fight Back

Crypto ATM Scams Surge in December 2025 as Police, States and Seniors Fight Back

Americans lost nearly $250 million to Bitcoin ATM scams in 2024, more than double the previous year, FBI data show. In Westlake, Ohio, police intervened as a 71-year-old woman tried to deposit $5,500 into a crypto ATM, one of several recent near-misses and losses. States including Nevada and Michigan issued new alerts in December. Crypto ATM operators now face lawsuits and enforcement actions in multiple states.
9 December 2025
Biggest Stock Losers Today on the U.S. Market (Dec. 9, 2025 Update)

Biggest Stock Losers Today on the U.S. Market (Dec. 9, 2025 Update)

Air Products & Chemicals shares plunged over 9% Monday, the worst drop in the S&P 500, after the company revealed talks with Yara International on a multibillion-dollar ammonia partnership. The Dow fell about 0.5% to 47,739, S&P 500 lost 0.4% to 6,846, and Nasdaq slipped 0.2%. Ten of eleven S&P 500 sectors declined as investors awaited Wednesday’s Federal Reserve rate decision.
9 December 2025
Stock Market Today: Dow Jones, S&P 500 and Nasdaq Eye Rebound as Fed Rate Cut and Nvidia China Deal Drive Wall Street — December 9, 2025

Stock Market Today: Dow Jones, S&P 500 and Nasdaq Eye Rebound as Fed Rate Cut and Nvidia China Deal Drive Wall Street — December 9, 2025

S&P 500, Dow, and Nasdaq futures edged higher early Tuesday after all three indexes slipped Monday but stayed just below record highs. Investors widely expect the Federal Reserve to cut rates by a quarter point Wednesday, with odds near 90%. Washington’s approval for Nvidia to sell H200 AI chips to select Chinese customers boosted tech futures. US 10-year Treasury yields rose to 4.19%, their highest since September.
Best Stocks to Buy Now in December 2025: 8 Top U.S. Picks as the Fed Prepares a Rate Cut

Best Stocks to Buy Now in December 2025: 8 Top U.S. Picks as the Fed Prepares a Rate Cut

U.S. stocks are near record highs as of December 9, 2025, with the S&P 500 up about 18% year to date, led by technology and AI firms. Inflation is running near 3%, and futures markets show an 85–89% chance the Federal Reserve will cut rates at its December meeting. Oppenheimer raised its S&P 500 year-end 2026 target to 8,100. AI-linked companies account for most of this year’s market gains.
9 December 2025
Paramount Skydance (PSKY) Stock: Warner Bros. Bid, Q3 Earnings and What December 2025 Means for Investors

Paramount Skydance (PSKY) Stock: Warner Bros. Bid, Q3 Earnings and What December 2025 Means for Investors

Paramount Skydance (NASDAQ: PSKY) traded near $14.60 on December 9, 2025, after rebounding on news of its $108.4 billion hostile bid for Warner Bros. Discovery. The stock’s 52-week range is $9.95–$20.86, with a market cap close to $16 billion. Most analyst price targets cluster between $13.90 and $14.70. PSKY formed in August after Skydance merged with Paramount Global.
Nvidia Stock Surges as U.S. Eases China AI Chip Ban: What NVDA Investors Need to Know on December 9, 2025

Nvidia Stock Surges as U.S. Eases China AI Chip Ban: What NVDA Investors Need to Know on December 9, 2025

President Donald Trump on Dec. 9 said his administration will allow Nvidia to sell H200 AI chips to approved customers in China, with the U.S. government taking a 25% cut of sales. The announcement came as prosecutors charged two men with smuggling Nvidia chips to China. Nvidia shares closed at $185.55, giving it a $4.5 trillion market cap, the world’s highest.
9 December 2025
Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough and $250M Equity Offering

Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough and $250M Equity Offering

Wave Life Sciences shares surged 147% to $18.52 after reporting positive Phase 1 data for its RNA obesity drug WVE-007 on December 8, raising its market cap to $3 billion. The company launched a $250 million equity offering following the rally. Interim results showed a 9.4% reduction in visceral fat and a 3.2% gain in lean mass after one dose, outperforming GLP-1 drugs in early comparisons.
Best Singapore Stocks to Buy Now (December 9, 2025): 8 SGX Picks for a Lower‑Rate World

Best Singapore Stocks to Buy Now (December 9, 2025): 8 SGX Picks for a Lower‑Rate World

Singapore’s Straits Times Index closed at 4,507.08 on Monday, just below record highs after a 19% annual gain. Short-term T-bill and fixed deposit yields have fallen below 1.5%, while 10-year government bonds hover near 2%. Lower yields are driving investors toward dividend stocks and REITs. Markets remain cautious ahead of the US Federal Reserve meeting this week.
Most Active Singapore Stocks Today (9 December 2025): Marco Polo Marine, Genting Singapore, Singtel and REITs Dominate SGX Turnover

Most Active Singapore Stocks Today (9 December 2025): Marco Polo Marine, Genting Singapore, Singtel and REITs Dominate SGX Turnover

Singapore’s Straits Times Index hovered near 4,509 on Tuesday as traders shifted into offshore and marine stocks, gaming, telcos, and REITs ahead of a key US Fed decision. Marco Polo Marine led volumes, jumping 7% on over 66 million shares traded. Genting Singapore, OxPay, and Aoxin Q & M also saw heavy activity. Blue chips DBS, Singtel, and SIA remained among the most traded.
Shell PLC (SHEL) Stock on 9 December 2025: Buybacks, New Oil Deals and What Analysts Forecast for 2026

Shell PLC (SHEL) Stock on 9 December 2025: Buybacks, New Oil Deals and What Analysts Forecast for 2026

Shell PLC closed at 2,750p in London and $72.70 in New York on 8 December 2025, both below recent highs. The company reported Q3 adjusted earnings of $5.4 billion and launched a $3.5 billion buyback programme, with daily share repurchases ongoing. Net debt fell to $41.2 billion. Shares remain near the top of their 12-month range.
GSK Stock Near 52-Week Highs: Upgraded 2025 Guidance, Buybacks and Zantac Relief Fuel Re‑Rating

GSK Stock Near 52-Week Highs: Upgraded 2025 Guidance, Buybacks and Zantac Relief Fuel Re‑Rating

GSK shares traded near 52-week highs on December 9, 2025, with London shares at £18.05 and NYSE ADRs at $48.5, both up over 30% year-on-year. The stock surged after a Q3 earnings beat and upgraded 2025 guidance, driven by strong HIV and oncology drug sales. GSK now expects full-year sales growth of 6–7% and core EPS growth of 10–12%.
Rio Tinto plc Stock Today: New CEO, $10 Billion Asset Sale Plan and Big 2026 Dividends as RIO Trades Near Highs

Rio Tinto plc Stock Today: New CEO, $10 Billion Asset Sale Plan and Big 2026 Dividends as RIO Trades Near Highs

Rio Tinto shares hovered near 52-week highs on 9 December 2025 after new CEO Simon Trott launched a major restructuring and upgraded the group’s copper outlook. The company flagged up to $10 billion in possible divestments and analysts expect higher dividends for 2026. London shares closed at 5,476p, up 16.5% year-to-date. Dividend yields are estimated between 4.7% and 5.7%.
Prudential plc (LON: PRU) Stock Update – Share Price, India JV IPO, Buybacks and 2025 Forecast as of 9 December 2025

Prudential plc (LON: PRU) Stock Update – Share Price, India JV IPO, Buybacks and 2025 Forecast as of 9 December 2025

Prudential plc shares closed at about 1,098p in London on December 8, up roughly 66% over the past year. The surge follows strong Asian growth, a major share buyback, and news that its India joint venture, ICICI Prudential AMC, will launch an IPO on December 12. Fitch and S&P upgraded Prudential’s ratings, though analysts warn of execution and regulatory risks.
Palantir (PLTR) Stock in December 2025: Buy or Sell After Michael Burry’s Big Bet and Cathie Wood’s Trims?

Palantir (PLTR) Stock in December 2025: Buy or Sell After Michael Burry’s Big Bet and Cathie Wood’s Trims?

Palantir shares have surged over 100% in 2025 and more than 2,000% since launching its AI platform, but the stock faces scrutiny over valuation and insider selling. Michael Burry disclosed a large put-option bet against Palantir, while Ark Invest trimmed its stake. Q3 revenue jumped 63% to about $1.2 billion, with US commercial revenue up 121%. Bank of America raised its price target to $255 despite valuation concerns.
Lloyds Banking Group Stock on 9 December 2025: Buyback Momentum, Stress‑Test Strength and What It Means for 2026

Lloyds Banking Group Stock on 9 December 2025: Buyback Momentum, Stress‑Test Strength and What It Means for 2026

Lloyds Banking Group shares closed at 95.70p on Monday, just below the £1 mark after a 75% surge in 2025. The bank repurchased nearly 10 million shares on 9 December as part of a £1.7 billion buyback. Lloyds’ market value stands near £57 billion, with a price/earnings ratio around 17x. Analyst sentiment remains positive, citing strong capital returns.
9 December 2025
Barclays PLC Stock (LON: BARC, NYSE: BCS) in December 2025: 60% Rally, Buybacks, Stress‑Test Win and a Big Wealth‑Management Bet

Barclays PLC Stock (LON: BARC, NYSE: BCS) in December 2025: 60% Rally, Buybacks, Stress‑Test Win and a Big Wealth‑Management Bet

Barclays shares traded near 437p on 8 December 2025, close to a multi-year high and up 63% over 12 months, making it a top FTSE 100 performer. The bank’s card data showed UK household spending fell 1.1% in November, the steepest drop since 2021. Barclays also passed the Bank of England’s 2025 stress test with a strong result. Speculation continues over a possible wealth-management acquisition.
9 December 2025
Biggest UK Stock Gainers Today (9 December 2025): Saga, Kainos and Empire Metals Lead London’s Winners

Biggest UK Stock Gainers Today (9 December 2025): Saga, Kainos and Empire Metals Lead London’s Winners

Saga plc jumped 8.36% to 317.50p on Monday, leading UK gainers after Kernow Asset Management predicted a 400% upside for the stock. Kainos Group rose 6.65%, Empire Metals added 5.98%, PayPoint gained 5.13%, and CRH advanced 4.88%. The FTSE 100 closed subdued as rising gilt yields and a weaker pound weighed on the broader market.
1 503 504 505 506 507 587

Stock Market Today

  • AMC Entertainment Valuation Review Amid 40% Weekly Share Surge
    June 4, 2026, 12:49 PM EDT. AMC Entertainment's stock rallied 40.4% in the past week, driven by strong momentum including an 87.6% gain over three months. Despite this surge, AMC remains down 38.4% over one year with ongoing operating losses of $547.4 million on $5 billion revenue. Current shares trade at $2.12 versus a blended fair value estimate of $2.03, suggesting a slight 4.3% overvaluation. The company is enhancing its cinema experience through premium formats to boost margins and revenue. However, box office remains below pre-pandemic levels, and capital structure depends on fresh equity and debt. Notably, AMC's price-to-sales ratio of 0.3x is well below sector averages, highlighting investor caution or opportunity. Investors face a mix of optimism and risk, demanding careful valuation analysis before investment decisions.

Latest articles

Nu Holdings Up After $1 Billion Buyback Plan, Analysts Cautious

4 June 2026
Shuttle Pharmaceuticals shares slid 3.2% to $0.507 as investors questioned its abrupt pivot from cancer-drug development to Dogecoin and Litecoin mining, with the stock trading well below the $1.03–$1.24 conversion prices in recent merger and financing deals and the company warning of substantial doubt about its ability to continue as a going concern.
High demand wipes out U.S. Mint $5,370 gold coin in minutes

High demand wipes out U.S. Mint $5,370 gold coin in minutes

4 June 2026
The U.S. Mint’s new $5,370 one-ounce American Eagle gold coin sold out in under two minutes, highlighting surging demand for physical gold investment, which Metals Focus says will overtake jewelry as the top gold demand driver this year; spot gold rose 1.7% to $4,505.35, but analysts warn high rates and a stronger dollar could pressure prices and premiums.
Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat

Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat

4 June 2026
Recursion shares surged about 12% to $3.87 on heavy volume ahead of its June 9 Goldman Sachs healthcare conference appearance, as investors look for updates on clinical timing, cash runway, and partnerships; small insider-sale filings were disclosed, and the move comes amid a broader rally in healthcare and AI drug-discovery stocks.
PVH Drops Hard as Calvin Klein Parent Issues Warning

PVH Drops Hard as Calvin Klein Parent Issues Warning

4 June 2026
PVH shares plunged 21% after the company slashed its annual sales outlook, blaming the Middle East conflict for a 5% EMEA revenue drop; despite beating first-quarter earnings estimates, the warning erased over a fifth of PVH’s market value as investors focused on EMEA demand risks, with the region making up 47% of sales.
Redwire Stock Gains After Space-Strawberry Announcement, More Ahead

Redwire Stock Gains After Space-Strawberry Announcement, More Ahead

4 June 2026
Redwire shares soared 14.6% to $21.33 after announcing a contract with Astrobiome Space for crop research on the ISS, marking the first commercial flight of its Greenhouse system; contract value was undisclosed, leaving investors to weigh the near-term financial impact as Redwire works to convert a record $498.1 million backlog into revenue following a recent Jefferies downgrade to Hold.
Go toTop